This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




Text Version  RSS  Subscribe  Unsubscribe  Archive  Media Kit August 14, 2015
Home    About AST    Education    Meetings & Events    Public Policy    Contact Us  

 



SOCIETY NEWS

It's time to compensate kidney donors
AST
Several AST members were quoted in a recent New York Times article regarding compensating living donors. Tina Rosenberg investigates the Iranian system of paying organ donors, and looks at how this system could be applied in the United States.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




The independent living donor advocate
AST
Many in the transplantation community have questions about what the ILDA role entails and how to operationalize it. To clear up the confusion, I have invited Rebecca Hays, chair of the AST’s Live Donor Community of Practice (LDCOP) to blog about recent steps the AST has taken to address the role of the ILDA.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ASN plans early program on transplantation in cooperation with AST at Kidney Week 2015
AST
Join the American Society of Nephrology, in cooperation with the American Society of Transplantation, for the Kidney Transplantation Early Program on Nov. 3 - 4 prior to the start of the Kidney Week 2015 Annual Meeting (Nov. 3-8) in San Diego, California. Visit the ASN website for more details and to register. Registration rates increase on Sept. 16.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
 
You care about your transplant patients. And so do we. That’s why we’re introducing Astellas Cares—a new program that offers you customized tools, educational resources, and comprehensive support to help your patients care for their health. To register, visit AstellasCares.com/Transplant today.
 


AST TIRN research grant request for proposals
AST
The AST Transplantation and Immunology Research Network (TIRN) research grants program supports fellows, junior faculty, and allied health professionals by funding innovative research in basic, clinical, and translational science. A limited number of grants will be awarded for research projects beginning July 1, 2016. The request for proposals is open now at www.TIRN.org/funding. Applications must be completed by 11:59 p.m. Pacific Standard Time on Sunday, November 1, 2015. For more information, visit www.TIRN.org or email TIRN@myAST.org.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Education and Clinical Tools for the Independent Living Donor Advocate: Webinar Aug. 19
AST
"Living Liver Donation A to Z: Understanding the Basics" is the next webinar in the Education and Clinical Tools for the Independent Living Donor Advocate (ILDA) webinar series, and takes place Wednesday, Aug. 19 at 1 p.m. EDT. The entire nine-webinar series developed by the AST Live Donor Community of Practice is free to AST members and their associates, just register with an AST member username and password at www.myAST.org/ILDA.

Non-members can purchase access to all nine webinars for just $200. Eligible non-members can join AST as a non-doctoral member and the webinar series is included in their $90 annual dues. Find out more at www.myAST.org/ILDA.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  UCLA Immunogenetics Center

The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
 


UPCOMING EVENTS IN TRANSPLANTATION

ASHI 41st Annual Meeting
ASHI
Sept. 28 - Oct. 2, 2015 | Savannah, GA
For more information: http://www.ashi-hla.org/events/annual-meeting/

2015 Banff/CST Joint Meeting
CST
Oct. 5-10, 2015 | Vancouver
For more information: http://www.cst-transplant.ca/meetings_asm.html

Society for Transplant Social Workers
STSW
Oct. 7-9, 2015 | Columbus, OH
For more information: https://www.stsw.org/conference/

ASN Kidney Week
ASN
Nov. 3-8, 2015 | San Diego, CA
For more information: https://www.asn-online.org/education/kidneyweek/

AASLD Liver Week
AASLD
Nov. 13-17, 2015 | San Francisco, CA
For more information: http://www.aasld.org/events-professional-development/liver-meeting

Save the date: CEOT 2016 – Cutting Edge of Transplantation
AST
Feb. 25-27, 2016 | Phoenix, AZ
For more information: http://2016.ceot.myast.org/

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




TRANSPLANT NEWS


High HLA-DP Expression and Graft-versus-Host Disease
The New England Journal of Medicine
Transplantation of hematopoietic cells from unrelated donors can cure blood disorders but carries a significant risk of acute graft-versus-host disease (GVHD). The risk is higher when the recipient and donor are HLA-DPB1–mismatched, but the mechanisms leading to GVHD are unknown. The HLA-DPB1 regulatory region variant rs9277534 is associated with HLA-DPB1 expression. We tested the hypothesis that the GVHD risk correlates with the rs9277534 allele linked to the mismatched HLA-DPB1 in the recipient.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Multicenter analysis of immune biomarkers and heart transplant outcomes: Results of the clinical trials in organ transplantation-05 study
American Journal of Transplantation
Identification of biomarkers that assess posttransplant risk is needed to improve long-term outcomes following heart transplantation. The Clinical Trials in Organ Transplantation (CTOT)-05 protocol was an observational, multicenter, cohort study of 200 heart transplant recipients followed for the first posttransplant year. The primary endpoint was a composite of death, graft loss/retransplantation, biopsy-proven acute rejection (BPAR), and cardiac allograft vasculopathy (CAV) as defined by intravascular ultrasound (IVUS).
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Missing or Broken Doppler Probes?

VTI’s disposable intraoperative Doppler probes are ready to verify technical results. There’s no longer the need to perform sterilization that frequently causes irreversible damage to the traditional Doppler probes. Advantages include fewer replacements of conventional Doppler probes damaged during sterilization, OR time saved, and a reduction in specialty procedures.
 


Adoptive transfer of renal allograft tolerance in a large animal model
American Journal of Transplantation
Our recent studies in an inbred swine model demonstrated that both peripheral and intra-graft regulatory cells were required for the adoptive transfer of tolerance to a second, naïve donor-matched kidney. Here, we have asked whether both peripheral and intra-graft regulatory elements are required for adoptive transfer of tolerance when only a long-term tolerant (LTT) kidney is transplanted. Nine highly-inbred swine underwent a tolerance-inducing regimen to prepare LTT kidney grafts which were then transplanted to histocompatible recipients, with or without the peripheral cell populations required for adoptive transfer of tolerance to a naïve kidney.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Fatal rituximab-associated lung injury syndrome in a patient treated with rituximab for recurrence of post-transplant nephrotic syndrome
Pediatric Transplantation
Rituximab (anti-B CD20 ab.) in recently widely used in renal transplantation. Case history: A 10-yr-old patient with end-stage renal failure due to multidrug-resistant NS was transplanted with renal graft from deceased donor and presented immediate recurrence of NS. PF was started on day 3 and patient received MP pulses, however with no effect. Rituximab (4 × 375 mg/m2) was administered. Chest radiographs taken at that time were normal.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Two-year post-transplantation cytomegalovirus DNAemia in asymptomatic kidney transplant recipients: Incidence, risk factors, and outcome
Transplant Infectious Disease
The incidence and the impact of asymptomatic cytomegalovirus (CMV) DNAemia occurring after the first year post transplantation is unknown. In this retrospective cross-sectional study, we analyzed the incidence, risk factors, and impact of 2-year post-transplantation asymptomatic CMV DNAemia (2YCD) on graft function.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Changes in risk profile over time in the population of a pediatric heart transplant program (The Annals of Thoracic Surgery via PubMed)
Nonchimeric HLA-identical renal transplant tolerance: Regulatory immunophenotypic/genomic biomarkers (American Journal of Transplantation)
Post-transplantation immunoadsorption can be withheld in ABO-incompatible kidney transplant recipients (Therapeutic Apheresis and Dialysis)
First report on the OPTN national variance: Allocation of A2/A2B deceased donor kidneys to blood group B increases minority transplantation (American Journal of Transplantation)

Don't be left behind. Click here to see what else you missed.
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Julie Bernhard, Executive Editor, 469.420.2647  
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
Aug. 7, 2015
July 31, 2015
July 24, 2015
July 17, 2015



Advertisement



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063